
AI
Enveda Secures $311M to Bring Nature-Derived AI Drugs Into Clinical Trials
AI biotech startup Enveda has raised $311 million in a funding round valuing the company at $2 billion as it advances natural-source drug candidates.
Tag
The latest news, analysis and stories about AI biotexnologiya — TECC.UZ.
1 articles

AI biotech startup Enveda has raised $311 million in a funding round valuing the company at $2 billion as it advances natural-source drug candidates.